Advancing immuno-oncology: Innovative solutions for adoptive cell therapy
Advances in immuno-oncology continue to transform cancer treatment, offering hope where traditional therapies have fallen short.
Watch this webinar to learn how advanced research tools are helping scientists understand treatment resistance caused by cancer stem cells (CSCs). We also discuss innovative solutions for studying CSCs and their role in treatment resistance, as well as co-culture systems for cancer cells and immune cells.
Key takeaways from the webinar:
- Innovative tools for isolating and cultivating CSCs
- Co-culture systems for studying cancer cell and immune cell interactions
- Advanced 3D tumor models for deeper tumor microenvironment insights
- Safety and precision considerations in adoptive cell therapies
Watch the video
Please fill out the form to access the video.
Related resources
The immunomodulatory properties of mesenchymal stem cells (MSCs)
Since their discovery in 1991, mesenchymal stem cells, or MSCs, have been used as a promising method to build tissue. However, MSCs can do more for the development of cell and gene therapies. Find out more in our video.
Application Note
HLA-Typed Primary Cells: The advantages of working with HLA in drug development research
For those working in drug development, human leukocyte antigens or HLA are a key element to keep in mind as an essential regulator of the immune system. Watch our latest explainer video to understand the benefits of working with HLA in your pre-clinical research.
Application Note
Cancer cell culture: Diversity of cells in the tumor microenvironment (TME)
Tumor growth is sustained by a highly diverse microenvironment, the TME. Its complex cellular interactions need serious consideration during Cancer Research.
Application Note
Obtain Pure Malignant Cells with the New Cancer Cell Culture Toolkit
The new cancer cell culture toolkit from PromoCell aids the growth of both primary tumors as well as established cells lines, explains Dr. Hagen Wieland during the AACR (American Association for Cancer Research) Annual Meeting in Chicago.
Application Note